These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 1359541)

  • 21. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
    Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
    Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
    Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
    Elson A
    Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.
    Andrechek ER; Hardy WR; Siegel PM; Rudnicki MA; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3444-9. PubMed ID: 10716706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
    Siegel PM; Dankort DL; Hardy WR; Muller WJ
    Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.
    Webster MA; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7849-53. PubMed ID: 7544006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene.
    Rao GN; Ney E; Herbert RA
    Breast Cancer Res Treat; 1999 Dec; 58(3):241-54. PubMed ID: 10718486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
    Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA
    Oncogene; 1993 Nov; 8(11):3037-42. PubMed ID: 7692372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer.
    Dickson RB; Salomon DS; Lippman ME
    Cancer Treat Res; 1992; 61():249-73. PubMed ID: 1360236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
    Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
    Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.
    Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA
    Cancer Cell; 2002 Dec; 2(6):451-61. PubMed ID: 12498714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
    Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
    Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
    Guy CT; Cardiff RD; Muller WJ
    Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.